Cyclerion Therapeutics (CYCN) Receivables - Net (2021 - 2025)
Historic Receivables - Net for Cyclerion Therapeutics (CYCN) over the last 5 years, with Q3 2025 value amounting to $100000.0.
- Cyclerion Therapeutics' Receivables - Net rose 12727.27% to $100000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $100000.0, marking a year-over-year increase of 12727.27%. This contributed to the annual value of $556000.0 for FY2024, which is N/A changed from last year.
- Cyclerion Therapeutics' Receivables - Net amounted to $100000.0 in Q3 2025, which was up 12727.27% from $525000.0 recorded in Q2 2025.
- In the past 5 years, Cyclerion Therapeutics' Receivables - Net ranged from a high of $581000.0 in Q1 2025 and a low of $44000.0 during Q3 2024
- Moreover, its 5-year median value for Receivables - Net was $192500.0 (2021), whereas its average is $244750.0.
- Its Receivables - Net has fluctuated over the past 5 years, first plummeted by 5770.93% in 2023, then skyrocketed by 12727.27% in 2025.
- Cyclerion Therapeutics' Receivables - Net (Quarter) stood at $100000.0 in 2021, then dropped by 4.0% to $96000.0 in 2022, then changed by 0.0% to $96000.0 in 2023, then skyrocketed by 479.17% to $556000.0 in 2024, then tumbled by 82.01% to $100000.0 in 2025.
- Its Receivables - Net was $100000.0 in Q3 2025, compared to $525000.0 in Q2 2025 and $581000.0 in Q1 2025.